Correction to: Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus

被引:0
|
作者
Yasuhiro Watanabe
Nobuichi Kuribayashi
Daigaku Uchida
Daisuke Suzuki
Mitsutoshi Kato
Daiji Nagayama
Hiroshi Ohashi
Masahiro Ohira
Atsuhito Saiki
Ichiro Tatsuno
机构
[1] Toho University Sakura Medical Center,Center of Diabetes, Endocrinology and Metabolism
[2] Misaki Naika Clinic,undefined
[3] Hotaruno Central Naika,undefined
[4] Suzuki Diabetes Clinic,undefined
[5] Kato Clinic of Internal Medicine,undefined
[6] Nagayama Clinic,undefined
[7] Oyama East Clinic,undefined
来源
Diabetes Therapy | 2020年 / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
In the original article, the 6th sentence of the section “FD and calorie intake” is incorrect. The correct sentence is “The protein component of FD consists of whey protein, casein, and soy protein”.
引用
收藏
页码:753 / 753
相关论文
共 50 条
  • [21] Effects of intensive exercise combined with dapagliflozin on body composition in patients with type 2 diabetes: a randomized controlled trial
    Bouchi, Ryotaro
    Sonoda, Noriyuki
    Itoh, Jun
    Ono, Yasuhiro
    Fukuda, Tatsuya
    Takeuchi, Takato
    Kishimoto, Junji
    Yamada, Tetsuya
    Ogawa, Yoshihiro
    ENDOCRINE JOURNAL, 2021, 68 (03) : 329 - 343
  • [22] The DAPA-DIET study: Metabolic response to Dapagliflozin combined with dietary carbohydrate restriction in patients with Type 2 Diabetes Mellitus and Obesity-A longitudinal cohort study
    Hanson, Petra
    Randeva, Harpal
    Cuthbertson, Dan J.
    O'Hare, Paul J.
    Parsons, Nick
    Chatha, Kamaljit
    Reidy, Gemma
    Weickert, Martin O.
    Barber, Thomas M.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (06)
  • [23] SGLT2-independent metabolic Effects of Dapagliflozin in Patients with Type 2 Diabetes
    Kahl, S.
    DIABETOLOGE, 2016, 12 (07): : 498 - 499
  • [24] Piileolithic type diet and metabolic control in healthy normals and type 2 diabetes mellitus
    Sherchan, Pooja
    Masharani, Umesh
    Angeli, Franca
    Gjerde, Christine
    Frassetto, Lynda
    DIABETES, 2008, 57 : A602 - A602
  • [25] The effects of dapagliflozin on the neovascularization of carotid atherosclerosis plaques in type 2 diabetes mellitus patients
    Li, Juanjuan
    Xin, Ying
    Wang, Fang
    Dong, Xiaoyun
    Xu, Lili
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 36 (01) : 231 - 238
  • [26] Impact of 24-week dapagliflozin treatment on body weight, body composition, and cardiac risk indicators of patients with type-2 diabetes mellitus
    Akhanli, Pinar
    Hepsen, Sema
    Arslan, Ismail Emre
    Duger, Hakan
    Bostan, Hayri
    Kizilgul, Muhammed
    Ucan, Bekir
    Cakal, Erman
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2023, 53 (05) : 1178 - 1184
  • [27] Metabolic and hepatic effects of cotadutide in diabetes mellitus type 2
    Pavlicek, Vojtech
    DIABETOLOGE, 2021, 17 (06): : 682 - 684
  • [28] The metabolic effects of troglitazone in type 2 diabetes mellitus and obesity
    Yu, JG
    Frias, J
    DIABETES, 1999, 48 : A119 - A119
  • [29] Effects of Exercise and Diet on Body Composition and Physical Function in Older Hispanics with Type 2 Diabetes
    Vieira, Edgar Ramos
    da Costa Cavalcanti, Fabricia Azevedo
    Civitella, Fernanda
    Hollifield, Monica
    Caceres, Stephanie
    Carreno, Jorge
    Gaillard, Trudy
    Huffman, Fatma G.
    Mora, Jorge Camilo
    Queiroga, Marcos Roberto
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (15)
  • [30] Cardiovascular and metabolic effects of paleolithic-type diets over american diabetes association diet in type 2 diabetes mellitus patients
    Angeli, F. Stedile
    Sherchan, P.
    Mccoy, S.
    Yeguiazarians, Y.
    Frassetto, L.
    Masharani, U.
    EUROPEAN HEART JOURNAL, 2010, 31 : 676 - 676